NASDAQ:RWLKRewalk Robotics Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Rewalk Robotics Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $1.39 +0.02 (+1.46 %) (As of 07/3/2020 04:00 PM ET) Add Compare Share Today's Range$1.30Now: $1.39▼$1.4850-Day Range$1.13MA: $1.53▼$1.9852-Week Range$0.41Now: $1.39▼$5.30Volume904,380 shsAverage Volume824,799 shsMarket Capitalization$17.97 millionP/E RatioN/ADividend YieldN/ABeta3.78 ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe. It is also developing ReWalk Restore, a soft suit exoskeleton for individuals who have suffered a stroke. ReWalk Robotics Ltd. markets and sells its products directly to third party payers, institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was founded in 2001 and is headquartered in Yokne'am Illit, Israel.Read More Beat the Market (BTM) Rank™ 3.5 Analyst's Opinion Consensus RatingRewalk Robotics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $3.50, Rewalk Robotics has a potential upside of 151.8% from its current price of $1.39.Amount of Analyst CoverageRewalk Robotics has received no research coverage in the past 90 days. Previous Next 3.1 Community Rank Outperform VotesRewalk Robotics has received 396 “outperform” votes. (Add your “outperform” vote.)Underperform VotesRewalk Robotics has received 253 “underperform” votes. (Add your “underperform” vote.)Community SentimentRewalk Robotics has received 61.02% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Rewalk Robotics and other stocks. Vote “Outperform” if you believe RWLK will outperform the S&P 500 over the long term. Vote “Underperform” if you believe RWLK will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldRewalk Robotics does not currently pay a dividend.Dividend GrowthRewalk Robotics does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Rewalk Robotics insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.10% of the stock of Rewalk Robotics is held by insiders.Percentage Held by InstitutionsOnly 10.79% of the stock of Rewalk Robotics is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Rewalk Robotics are expected to grow in the coming year, from ($1.02) to ($0.45) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Rewalk Robotics is -0.63, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Rewalk Robotics is -0.63, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioRewalk Robotics has a P/B Ratio of 0.94. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.5Community Rank: 3.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.57 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical appliances & supplies Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:RWLK Previous Symbol CUSIPN/A CIK1607962 Webwww.rewalk.com Phone972-4959-0123Debt Debt-to-Equity RatioN/A Current Ratio2.12 Quick Ratio1.80Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$4.87 million Price / Sales3.69 Cash FlowN/A Price / Cash FlowN/A Book Value$1.48 per share Price / Book0.94Profitability EPS (Most Recent Fiscal Year)($2.70) Net Income$-15,550,000.00 Net Margins-379.84% Return on Equity-111.44% Return on Assets-55.97%Miscellaneous Employees58 Outstanding Shares12,930,000Market Cap$17.97 million Next Earnings Date8/13/2020 (Estimated) OptionableNot Optionable NASDAQ:RWLK Rates by TradingView Receive RWLK News and Ratings via Email Sign-up to receive the latest news and ratings for RWLK and its competitors with MarketBeat's FREE daily newsletter. Rewalk Robotics (NASDAQ:RWLK) Frequently Asked Questions How has Rewalk Robotics' stock been impacted by COVID-19 (Coronavirus)? Rewalk Robotics' stock was trading at $0.6050 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, RWLK shares have increased by 129.8% and is now trading at $1.39. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Rewalk Robotics? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rewalk Robotics in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Rewalk Robotics. When is Rewalk Robotics' next earnings date? Rewalk Robotics is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for Rewalk Robotics. How were Rewalk Robotics' earnings last quarter? Rewalk Robotics Ltd (NASDAQ:RWLK) announced its quarterly earnings results on Thursday, May, 28th. The medical device company reported ($0.37) earnings per share for the quarter, missing the consensus estimate of ($0.26) by $0.11. The medical device company earned $0.76 million during the quarter, compared to the consensus estimate of $2.20 million. Rewalk Robotics had a negative net margin of 379.84% and a negative return on equity of 111.44%. View Rewalk Robotics' earnings history. What price target have analysts set for RWLK? 1 brokers have issued 12-month target prices for Rewalk Robotics' stock. Their forecasts range from $3.50 to $3.50. On average, they anticipate Rewalk Robotics' stock price to reach $3.50 in the next twelve months. This suggests a possible upside of 151.8% from the stock's current price. View analysts' price targets for Rewalk Robotics. Has Rewalk Robotics been receiving favorable news coverage? Media coverage about RWLK stock has trended negative recently, according to InfoTrie. The research firm identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Rewalk Robotics earned a media sentiment score of -2.1 on InfoTrie's scale. They also gave media coverage about the medical device company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news about Rewalk Robotics. Who are some of Rewalk Robotics' key competitors? Some companies that are related to Rewalk Robotics include COLLPLANT HOLDI/S (CLGN), ConforMIS (CFMS), Allied Healthcare Products (AHPI), Histogenics (HSGX), Precision Therapeutics (POAI), Ocugen (OCGN), NanoVibronix (NAOV), Bionik Laboratories (BNKL) and Avitar (AVTI). View all competitors. What other stocks do shareholders of Rewalk Robotics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Rewalk Robotics investors own include Chembio Diagnostics (CEMI), Prospect Capital (PSEC), Calumet Specialty Products Partners, L.P (CLMT), Two Harbors Investment (TWO), Novocure (NVCR), Blackrock Capital Investment (BKCC), Summit Midstream Partners (SMLP), Viper Energy Partners (VNOM), Washington Prime Group (WPG) and Roper Technologies (ROP). Who are Rewalk Robotics' key executives? Rewalk Robotics' management team includes the following people: Mr. Lawrence J. Jasinski, CEO & Director (Age 62)Mr. Ori Gon, Chief Financial Officer (Age 38)Ms. Miri Pariente, VP of QA & Operations (Age 42)Mr. Loren Wass, VP of Sales & ReimbursementMr. Andy Dolan, VP of Marketing What is Rewalk Robotics' stock symbol? Rewalk Robotics trades on the NASDAQ under the ticker symbol "RWLK." How do I buy shares of Rewalk Robotics? Shares of RWLK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Rewalk Robotics' stock price today? One share of RWLK stock can currently be purchased for approximately $1.39. How big of a company is Rewalk Robotics? Rewalk Robotics has a market capitalization of $17.97 million and generates $4.87 million in revenue each year. The medical device company earns $-15,550,000.00 in net income (profit) each year or ($2.70) on an earnings per share basis. Rewalk Robotics employs 58 workers across the globe. What is Rewalk Robotics' official website? The official website for Rewalk Robotics is www.rewalk.com. How can I contact Rewalk Robotics? Rewalk Robotics' mailing address is 3 Hatnufa Street Floor 6, Yokneam Ilit L3, 2069203. The medical device company can be reached via phone at 972-4959-0123 or via email at [email protected] This page was last updated on 7/6/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
